Clinical Trial Update: Adjuvant AI Combined With Zoladex [Phase 3]

View source ↗

Summary

Phase 3 trial update investigating adjuvant aromatase inhibitor combined with Zoladex for breast cancer; current status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromatase inhibitor (Aromatase inhibitor)
• Zoladex (goserelin)

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN